News for Cell MedX Corp. (CMXC)

The Dow Jones index closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Cell MedX Corp. announces that on November 22, 2023, the British Columbia Securities Commission issued an order revoking the Cease Trade Order previously issued by the Commission on October 11,...

Cell MedX Corp. reported earnings results for the full year ended May 31, 2023. For the full year, the company reported sales was USD 0.002762 million compared to USD 0.006065 million a year ago.Net...

Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance Carson City, Nevada, October 18, 2022, Cell MedX Corp. , a biotech... | October 18, 2022

Read Cell MedX Corp. (OTCMKTS:CMXC) Short Interest Update at ETF Daily News

Cell MedX Corp. (OTCMKTS:CMXC) shares were down 5.4% on Wednesday . The company traded as low as $0.13 and last traded at $0.15. Approximately 23,700 shares changed hands during trading, an increase of 97% from the average daily volume of 12,045 shares. The stock had previously closed at $0.16. The business’s 50-day simple moving average […]

Cell MedX Corp. , a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that... | September 17, 2021

Mailing Address 123 W. NYE LN, SUITE 446 CARSON CITY NV 89706 Business Address 123 W. NYE LN, SUITE 446 CARSON CITY NV 89706 (844) 238-2692 CIK : 0001493712 (...